Email ID
Password
Sign me in automatically next time
Regulatory Affairs Medtech
Advancing regenerative medicine in the US requires regulatory change
27 April 2011
Michael J Werner

Americans have been engaged in a detailed and politically charged debate about healthcare reform for the past few years, but there has been surprisingly little discussion about ways new technologies such as regenerative medicine can improve clinical care and reduce spending. These innovative technologies may represent our best hope for dealing with the challenges – primarily due to an ageing population – that lie ahead

...

Please Login to read the full article.
 
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36